214 related articles for article (PubMed ID: 33220356)
21. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
22. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969
[TBL] [Abstract][Full Text] [Related]
23. Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy.
Papasotiriou M; Stangou M; Chlorogiannis D; Marinaki S; Xydakis D; Sampani E; Lioulios G; Kapsia E; Zerbala S; Koukoulaki M; Moustakas G; Fokas S; Dounousi E; Duni A; Papadaki A; Damianakis N; Bacharaki D; Stylianou K; Gakiopoulou H; Liapis G; Sakellaropoulos G; Papachristou E; Boletis I; Papagianni A; Goumenos DS
Front Med (Lausanne); 2022; 9():778464. PubMed ID: 35242773
[TBL] [Abstract][Full Text] [Related]
24. Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.
Kataoka H; Ohara M; Suzuki T; Inoue T; Akanuma T; Kawachi K; Manabe S; Ushio Y; Kawasoe K; Akihisa T; Sato M; Iwasa N; Sawara Y; Honda K; Mochizuki T; Tsuchiya K; Nitta K
PLoS One; 2020; 15(5):e0232885. PubMed ID: 32379841
[TBL] [Abstract][Full Text] [Related]
25. Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool.
Barbour SJ; Canney M; Coppo R; Zhang H; Liu ZH; Suzuki Y; Matsuzaki K; Katafuchi R; Induruwage D; Er L; Reich HN; Feehally J; Barratt J; Cattran DC;
Kidney Int; 2020 Oct; 98(4):1009-1019. PubMed ID: 32464215
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
Chen J; Xu H; Peng Z; Lin L; Li C; Zhu X; Liu S
Clin Exp Nephrol; 2020 Jan; 24(1):73-81. PubMed ID: 31605314
[TBL] [Abstract][Full Text] [Related]
27. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
[TBL] [Abstract][Full Text] [Related]
28. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Peruzzi L; Amore A; Lundberg S; Di Palma AM; Gesualdo L; Emma F; Rollino C; Praga M; Biancone L; Pani A; Feriozzi S; Polci R; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Durlik M; Moggia E; Ballarin JC; Wetzels JFM; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Benozzi L; Cusinato S; Berg U; Topaloglu R; Maggio M; Ots-Rosenberg M; D'Amico M; Geddes C; Balafa O; Quaglia M; Cravero R; Lino Cirami C; Fellstrom B; Floege J; Egido J; Mallamaci F; Zoccali C;
Nephrol Dial Transplant; 2020 Jun; 35(6):1002-1009. PubMed ID: 30418652
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
[TBL] [Abstract][Full Text] [Related]
30. Predictive Capabilities of Three Widely Used Pathology Classification Systems and a Simplified Classification (Beijing Classification) in Primary IgA Nephropathy.
Duan SW; Mei Y; Liu J; Chen P; Li P; Chen YZ; Lin SP; Zhang XG; Liu JN; Sun XF; Xie YS; Cai GY; Liu SW; Wu J; Chen XM
Kidney Blood Press Res; 2019; 44(5):928-941. PubMed ID: 31461707
[TBL] [Abstract][Full Text] [Related]
31. Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy.
Feehally J; Coppo R; Troyanov S; Bellur SS; Cattran D; Cook T; Roberts IS; Verhave JC; Camilla R; Vergano L; Egido J; Wiecek A; Karkoszka H; Tesar V; Maixnerova D; Ots-Rosenberg M; Quaglia M; Rollino C; Magistroni R; Cusinato S; Cravero R; Peruzzi L; Lundberg S; Gesualdo L; Cancarini G; Feriozzi S; Ferrario F;
Nephron; 2016; 132(1):15-24. PubMed ID: 26586175
[TBL] [Abstract][Full Text] [Related]
32. Crescentic IgA nephropathy in children.
Shima Y; Nakanishi K; Hama T; Mukaiyama H; Sato M; Tanaka Y; Tanaka R; Kaito H; Nozu K; Sako M; Iijima K; Yoshikawa N
Pediatr Nephrol; 2020 Jun; 35(6):1005-1014. PubMed ID: 31993782
[TBL] [Abstract][Full Text] [Related]
33. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
[TBL] [Abstract][Full Text] [Related]
34. Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients.
Pesce F; Diciolla M; Binetti G; Naso D; Ostuni VC; Di Noia T; Vågane AM; Bjørneklett R; Suzuki H; Tomino Y; Di Sciascio E; Schena FP
Nephrol Dial Transplant; 2016 Jan; 31(1):80-6. PubMed ID: 26047632
[TBL] [Abstract][Full Text] [Related]
35. Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy.
Chen T; Li X; Li Y; Xia E; Qin Y; Liang S; Xu F; Liang D; Zeng C; Liu Z
Am J Kidney Dis; 2019 Sep; 74(3):300-309. PubMed ID: 31031086
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Outcomes of Patients with IgA Nephropathy Categorized by the International IgAN Risk Prediction Tool and by the Degree of Hematuria at Diagnosis.
Ebbestad R; Sanaei Nurmi M; Lundberg S
Nephron; 2022; 146(6):573-583. PubMed ID: 35671707
[TBL] [Abstract][Full Text] [Related]
37. IgA Nephropathy in Children: A Multicenter Study in Poland.
Mizerska-Wasiak M; Turczyn A; Such A; Cichoń-Kawa K; Małdyk J; Miklaszewska M; Pietrzyk J; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Szczepańska M; Bieniaś B; Zajączkowska M; Pukajło-Marczyk A; Zwolińska D; Siniewicz-Luzeńczyk K; Tkaczyk M; Gadomska-Prokop K; Grenda R; Demkow U; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2016; 952():75-84. PubMed ID: 27573641
[TBL] [Abstract][Full Text] [Related]
38. Pregnancy and Kidney Outcomes in Patients With IgA Nephropathy: A Cohort Study.
Su X; Lv J; Liu Y; Wang J; Ma X; Shi S; Liu L; Zhang H
Am J Kidney Dis; 2017 Aug; 70(2):262-269. PubMed ID: 28320554
[TBL] [Abstract][Full Text] [Related]
39. Steroid therapy in children with IgA nephropathy.
Cambier A; Boyer O; Deschenes G; Gleeson J; Couderc A; Hogan J; Robert T
Pediatr Nephrol; 2020 Mar; 35(3):359-366. PubMed ID: 30778826
[TBL] [Abstract][Full Text] [Related]
40. Arteriolar C4d in IgA Nephropathy: A Cohort Study.
Faria B; Canão P; Cai Q; Henriques C; Matos AC; Poppelaars F; Gaya da Costa M; Daha MR; Silva R; Pestana M; Seelen MA
Am J Kidney Dis; 2020 Nov; 76(5):669-678. PubMed ID: 32439421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
